| Medicinal oils series |
Soybean Oil |
CP/USP |
8001-22-7 |
CDE registration No.F20209990540，status “A” |
| Medicinal oils series |
Purified Olive Oil（For Injection） |
USP/EP |
8001-25-0 |
CDE registration No.Y20190000997，status “A” |
| Medicinal oils series |
Structured Triglyceride |
Enterprise Standard |
-- |
R&D |
| Medicinal oils series |
Purified Fish Oil |
USP/EP |
8016-13-5 |
R&D |
| Medicinal oils series |
Sodium Oleate（For injection） |
Enterprise Standard |
16558-02-4 |
CDE registration No.F20220000120 |
| Medicinal oils series |
Soybean Oil for Injection |
CP/USP/EP |
8001-22-7 |
CDE registration No.Y20190000635，status “A” |
| Medicinal oils series |
Medium Chain Triglycerides |
CP/USP/EP |
65381-09-1 |
CDE registration No.Y20200001227，status “A” |
| Medicinal Phospholipids series |
Purified Egg lecithin / Egg Phospholipids |
CP/USP/EP |
93685-90-6 |
CDE registration No.F20190001049，status “A”，DMF#35483 |
| Medicinal Phospholipids series |
Egg Phosphatidyl Choline |
CP |
93685-90-6 |
CDE registration No.F20170000086，status “A” |
| Medicinal Phospholipids series |
Polyene Phosphatidyl Choline |
Enterprise Standard |
8002-43-5 |
R&D |
| Medicinal Phospholipids series |
Cholesterol（For injection） |
CP |
57-88-5 |
CDE registration No.F20170000625，status “A” |
| Medicinal Phospholipids series |
DSPE |
Enterprise Standard |
1069-79-0 |
R&D |
| Medicinal Phospholipids series |
DOPE |
Enterprise Standard |
4004-05-1 |
R&D |
| Medicinal Phospholipids series |
EPG |
Enterprise Standard |
383907-64-0 |
R&D |
| Medicinal Phospholipids series |
DSPC |
Enterprise Standard |
816-94-4 |
R&D |
| Medicinal Phospholipids series |
DOPC |
Enterprise Standard |
4235-95-4 |
R&D |
| Medicinal Phospholipids series |
Sphingomyelin/SM |
Enterprise Standard |
383907-87-7 |
R&D |
| Medicinal Phospholipids series |
DSPG-Na |
Enterprise Standard |
200880-42-8 |
R&D |
| Medicinal Phospholipids series |
DPPG-Na |
Enterprise Standard |
67232-81-9 |
R&D |
| Oncology APIs |
Vincristine Sulfate |
CP/USP/EP/IP |
2068-78-2 |
CDE registration No.Y20190009906，status “A”，DMF#18579 |
| Oncology APIs |
Vinblastine Sulfate |
CP/USP/EP/IP |
143-67-9 |
CDE registration No.Y20190007637，status “A” |
| Oncology APIs |
Vinorelbine Tartrate |
CP/USP/EP/IP |
125317-39-7 |
CDE registration No.Y20190006188，status “A”，DMF#25783 |
| Oncology APIs |
Vindesine Sulfate |
CP/EP |
59917-39-4 |
CDE registration No.Y20190007636，status “A” |
| Cardiovascular APIs |
Methyl Hesperidin |
National Drug Standard |
11013-97-1 |
CDE registration No.Y20190007574，status “A” |
| Cardiovascular APIs |
Tolperisone Hcl |
National Drug Standard |
3644-61-9 |
CDE registration No.Y20190008322，status “A” |
| Cardiovascular APIs |
Metoprolol Tartrate |
CP |
56392-17-7 |
CDE registration No.Y20190007575，status “A” |
| Cardiovascular APIs |
Trimetazidine Hcl |
CP |
13171-25-0 |
CDE registration No.Y20190007374，status “A” |
| Anticholinergic APIs |
Scopolamine Hydrobromide |
CP |
114-49-8 |
CDE registration No.Y20190001970，status “A” |
| Anticholinergic APIs |
Scopolamine Butylbromide |
CP/EP |
149-64-4 |
CDE registration No.Y20190007630，status “A” |
| Others |
Propyl Gallate |
CP/USP/EP |
121-79-9 |
CDE registration No.Y20190007577，status “A” |
| Others |
Bifonazole |
CP |
60628-96-8 |
CDE registration No.Y20190007629，status “A” |
| Others |
Clotrimazole |
CP |
23593-75-1 |
CDE registration No.Y20190007626，status “A” |
| Functional additive |
Eggyolk oil |
Enterprise Standard |
8001-17-0 |
-- |
| Functional additive |
Egg Protein Powder |
Enterprise Standard |
-- |
-- |
